Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||-0.58%||450.57||2.7%||$528.56m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.20%||212.55||1.9%||$509.80m|
|GILD||Gilead Sciences, Inc.||-2.21%||61.40||1.0%||$483.93m|
|BNGO||BioNano Genomics, Inc.||-2.89%||9.73||0.0%||$394.84m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.59%||152.75||2.0%||$382.70m|
|CRSP||CRISPR Therapeutics AG||-1.25%||125.69||0.6%||$298.18m|
|EXAS||EXACT Sciences Corp.||3.67%||136.12||18.4%||$255.24m|
|SRNE||Sorrento Therapeutics, Inc.||-4.45%||9.67||1.3%||$229.08m|
Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.